Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-150 in acute pain following bunionectomy
NCT03764072Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Dec 2018
- Primary completion
- Jan 2019
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VX-150 in acute pain, sponsored by Vertex Pharmaceuticals. Started Dec 2018; status: completed.
02
Drugs
VX-150
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03764072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764072.